RCMI Coordinating Center (RCMI CC) Header Logo

Carrie House

TitleAssociate Professor
Faculty RankAssociate Professor
InstitutionSan Diego State University
DepartmentBiology
Address5500 Campanile Dr
BSCI 2104
San Diego CA 92182
Phone6195943053
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    The George Washington University, Washington, DCPhD05/2011Molecular Medicine
    National Cancer Institute, Bethesda, MD06/2018Postdoctoral Training

    Collapse Overview 
    Collapse overview
    Dr. House is an Assistant Professor of Cancer Biology in the Biology Department at San Diego State University (SDSU). She received a BS in Biology from George Mason University in 2004. She then completed a postbaccalaureate fellowship at the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health (NIH). She received her PhD in Molecular Medicine from The George Washington University in 2011. Her graduate work focused on clarifying the role of voltage-activated ion channels in colon cancer progression. Dr. House then completed her postdoctoral training at the National Cancer Institute at NIH, where she investigated the NF-kB signaling pathway in chemotherapy resistant ovarian cancer stem cells. Dr. House joined SDSU in 2018 where her lab continues to investigate mechanisms of ovarian cancer relapse and the role of the tumor microenvironment in supporting chemotherapy resistance. She also is the Co-Leader of the Weight in Cancer Research Project of SDSU HealthLINK Center.

    Collapse Research 
    Collapse research activities and funding
    R00CA204727     (HOUSE, CARRIE DANIELLE)Jan 1, 2020 - Jul 31, 2021
    NIH
    Role of NF-kB signaling in supporting ovarian cancer tumor-initiating cells responsible for cancer recurrence
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Carlson N, House CD, Tambasco M. Toward a Transportable Cell Culture Platform for Evaluating Radiotherapy Dose Modifying Factors. Int J Mol Sci. 2023 Nov 03; 24(21). PMID: 37958936.
      Citations:    Fields:    Translation:Humans
    2. Harrington BS, Kamdar R, Ning F, Korrapati S, Caminear MW, Hernandez LF, Butcher D, Edmondson EF, Traficante N, Hendley J, Gough M, Rogers R, Lourie R, Shetty J, Tran B, Elloumi F, Abdelmaksoud A, Nag ML, Mazan-Mamczarz K, House CD, Hooper JD, Annunziata CM. UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer. J Exp Clin Cancer Res. 2023 Oct 19; 42(1):270. PMID: 37858159.
      Citations:    Fields:    Translation:HumansAnimalsCells
    3. Kamdar RD, Harrington BS, Attar E, Korrapati S, Shetty J, Zhao Y, Tran B, Wong N, House CD, Annunziata CM. NF-?B Signaling Modulates miR-452-5p and miR-335-5p Expression to Functionally Decrease Epithelial Ovarian Cancer Progression in Tumor-Initiating Cells. Int J Mol Sci. 2023 Apr 25; 24(9). PMID: 37175530.
      Citations:    Fields:    Translation:HumansCells
    4. Holmberg R, Robinson M, Gilbert SF, Lujano-Olazaba O, Waters JA, Kogan E, Velasquez CLR, Stevenson D, Cruz LS, Alexander LJ, Lara J, Mu EM, Camillo JR, Bitler BG, Huxford T, House CD. TWEAK-Fn14-RelB Signaling Cascade Promotes Stem Cell-like Features that Contribute to Post-Chemotherapy Ovarian Cancer Relapse. Mol Cancer Res. 2023 02 01; 21(2):170-186. PMID: 36214671.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    5. Waters JA, Urbano I, Robinson M, House CD. Insulin-like growth factor binding protein 5: Diverse roles in cancer. Front Oncol. 2022; 12:1052457. PMID: 36465383.
      Citations:    
    6. Robinson M, Gilbert SF, Waters JA, Lujano-Olazaba O, Lara J, Alexander LJ, Green SE, Burkeen GA, Patrus O, Sarwar Z, Holmberg R, Wang C, House CD. Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating Cells. Cancers (Basel). 2021 Jan 12; 13(2). PMID: 33445692.
      Citations:    
    7. Harrington BS, Ozaki MK, Caminear MW, Hernandez LF, Jordan E, Kalinowski NJ, Goldlust IS, Guha R, Ferrer M, Thomas C, Shetty J, Tran B, Wong N, House CD, Annunziata CM. Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model. Cancers (Basel). 2020 Jun 21; 12(6). PMID: 32575908.
      Citations:    
    8. House CD, Jordan E, Hernandez L, Ozaki M, James JM, Kim M, Kruhlak MJ, Batchelor E, Elloumi F, Cam MC, Annunziata CM. NF?B Promotes Ovarian Tumorigenesis via Classical Pathways That Support Proliferative Cancer Cells and Alternative Pathways That Support ALDH+ Cancer Stem-like Cells. Cancer Res. 2017 12 15; 77(24):6927-6940. PMID: 29074539.
      Citations: 51     Fields:    Translation:HumansAnimalsCells
    9. Hernandez L, Kim MK, Lyle LT, Bunch KP, House CD, Ning F, Noonan AM, Annunziata CM. Characterization of ovarian cancer cell lines as in vivo models for preclinical studies. Gynecol Oncol. 2016 08; 142(2):332-40. PMID: 27235858.
      Citations: 55     Fields:    Translation:HumansAnimalsCells
    10. House CD, Hernandez L, Annunziata CM. In vitro enrichment of ovarian cancer tumor-initiating cells. J Vis Exp. 2015 Feb 18; (96). PMID: 25742116.
      Citations: 20     Fields:    Translation:HumansAnimalsCells
    11. House CD, Hernandez L, Annunziata CM. Recent technological advances in using mouse models to study ovarian cancer. Front Oncol. 2014; 4:26. PMID: 24592355.
      Citations:    
    House's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (40)
    Explore
    _
    Co-Authors (3)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support